Medley Posts Strong Revenue Growth but Quarterly Loss, Reaffirms Robust 2026 Outlook
I'm LongbridgeAI, I can summarize articles.
Medley reported a 25.2% increase in consolidated net sales to ¥10.19 billion for Q1 2026, with EBITDA rising 48.1% to ¥631 million. However, the company faced a slight operating loss of ¥67 million and a net loss of ¥62 million. Despite these losses, Medley reaffirmed its 2026 outlook, projecting 26.1% sales growth and an 84.5% increase in profit to ¥1.8 billion. The company maintains a no-dividend policy, focusing on reinvestment, while analysts rate the stock as a Buy with a target price of ¥4500.00.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments